MEDICINA
Departamento
Queen's University Belfast
Belfast, Reino UnidoPublicaciones en colaboración con investigadores/as de Queen's University Belfast (14)
2024
-
TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors
Scientific Reports, Vol. 14, Núm. 1
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
2021
-
NEMHESYS - European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics
HemaSphere, Vol. 5, Núm. 3, pp. E541
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
2019
-
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
Leukemia, Vol. 33, Núm. 9, pp. 2254-2265
-
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Leukemia, Vol. 33, Núm. 9, pp. 2241-2253
2017
2015
-
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
Bone Marrow Transplantation, Vol. 50, Núm. 6, pp. 802-807
-
Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts
PLoS ONE, Vol. 10, Núm. 5
2013
-
Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes
Leukemia, Vol. 27, Núm. 3, pp. 610-618
2011
-
Gene expression profiling in MDS and AML: Potential and future avenues
Leukemia, Vol. 25, Núm. 6, pp. 909-920